Stay updated on Nivolumab in Metastatic Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Metastatic Bladder Cancer Clinical Trial page.

Latest updates to the Nivolumab in Metastatic Bladder Cancer Clinical Trial page
- CheckyesterdayChange DetectedUpdated the Italy location entry from Napoli, Italy, 80131 to Naples, Italy, 80131 and updated the revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.3%

- Check51 days agoChange DetectedAdded a site-wide funding status notice and updated the page revision to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.3%

- Check58 days agoChange DetectedAdded a 'Show glossary' option and updated labels for QC criteria mentions and FEAR Act notices, including capitalization changes and a revision tag update from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page shows Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in Metastatic Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Metastatic Bladder Cancer Clinical Trial page.